TABLE 3

Biodistribution of [99mTc]Demobesin 4 in Human PC3 Xenograft–Bearing SCID Mice at 1, 4, and 24 Hours After Injection

[99mTc]Demobesin 4
Organ1 h4 h24 h
Blood1.40 ± 0.510.07 ± 0.010.07 ± 0.02
Liver1.26 ± 0.350.63 ± 0.090.32 ± 0.02
Heart0.68 ± 0.240.19 ± 0.030.08 ± 0.01
Kidneys12.84 ± 3.617.41 ± 1.161.83 ± 0.27
Stomach0.96 ± 0.440.34 ± 0.060.38 ± 0.01
Intestines5.20 ± 1.515.79 ± 0.741.06 ± 0.02
Blocked intestines*ND1.23 ± 0.21ND
Spleen2.23 ± 0.531.85 ± 0.560.84 ± 0.59
Muscle0.31 ± 0.100.03 ± 0.000.06 ± 0.02
Lungs1.33 ± 0.270.27 ± 0.050.25 ± 0.13
Pancreas38.90 ± 8.4134.80 ± 4.7514.43 ± 2.65
Blocked pancreas*ND0.68 ± 0.04ND
PC3 tumor9.37 ± 2.525.19 ± 0.592.67 ± 0.29
Blocked tumor*ND0.55 ± 0.4ND
Tumor/blood6.6974.1438.14
Tumor/muscle30.23173.0044.50
Tumor/liver7.448.248.34
Tumor/kidney0.730.701.46
  • * In vivo blockade was achieved by coinjection of 100 μg [Tyr4]bombesin.

  • Statistical analysis was performed using the Student t test with P values indicating extremely significant difference (P < 0.001) vs. unblocked.

  • ND = not determined.

  • Data are expressed as ID%/g (percentage injected dose per gram) and are presented as mean ± SD (n = 4).